Enterococcus faecalis endocarditis: what's next?
- PMID: 32286105
- DOI: 10.2217/fmb-2019-0247
Enterococcus faecalis endocarditis: what's next?
Abstract
Enterococcus faecalis infective endocarditis (EFIE) is a complex entity in rapid evolution. Although largely relevant findings from recent studies have advanced the knowledge on EFIE and led to some changes in clinical guidelines, there are still a number of gaps to be filled. Coordinated, international, multicenter efforts are needed to obtain quality data that rend the health systems and scientific community prepared enough to understand and handle this infection. In this Perspective, some of the most relevant aspects concerning the epidemiology, clinical presentation and outcomes, diagnostic approaches and antibiotic therapy of EFIE are addressed. Also, several potential future clinical developments in the field are discussed.
Keywords: Enterococcus faecalis; antibiotic treatment; colorectal neoplasm; echocardiography; endocarditis; epidemiology; outcomes.
Similar articles
-
Secular trends in the epidemiology and clinical characteristics of Enterococcus faecalis infective endocarditis at a referral center (2007-2018).Eur J Clin Microbiol Infect Dis. 2021 Jun;40(6):1137-1148. doi: 10.1007/s10096-020-04117-x. Epub 2021 Jan 6. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33404892
-
Relationship Between Enterococcus faecalis Infective Endocarditis and Colorectal Neoplasm: Preliminary Results From a Cohort of 154 Patients.Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):451-458. doi: 10.1016/j.rec.2016.10.013. Epub 2017 Mar 9. Rev Esp Cardiol (Engl Ed). 2017. PMID: 27916708 English, Spanish.
-
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study.Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):711-717. doi: 10.1016/j.rec.2019.07.007. Epub 2019 Aug 20. Rev Esp Cardiol (Engl Ed). 2020. PMID: 31444092 English, Spanish.
-
Enterococcus faecalis infective endocarditis: focus on clinical aspects.Expert Rev Cardiovasc Ther. 2013 Sep;11(9):1247-57. doi: 10.1586/14779072.2013.832482. Expert Rev Cardiovasc Ther. 2013. PMID: 24073680 Review.
-
Revisiting the Evidence Base That Informs the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-Analysis.Clin Infect Dis. 2024 Nov 22;79(5):1162-1171. doi: 10.1093/cid/ciae379. Clin Infect Dis. 2024. PMID: 39041860
Cited by
-
Microdiversity of Enterococcus faecalis isolates in cases of infective endocarditis: selection of non-synonymous mutations and large deletions is associated with phenotypic modifications.Emerg Microbes Infect. 2021 Dec;10(1):929-938. doi: 10.1080/22221751.2021.1924865. Emerg Microbes Infect. 2021. PMID: 33913790 Free PMC article.
-
Treatment of Enterococcus faecalis Infective Endocarditis: A Continuing Challenge.Antibiotics (Basel). 2023 Apr 4;12(4):704. doi: 10.3390/antibiotics12040704. Antibiotics (Basel). 2023. PMID: 37107066 Free PMC article. Review.
-
In Vitro Synergism of Penicillin and Ceftriaxone against Enterococcus faecalis.Microorganisms. 2021 Oct 14;9(10):2150. doi: 10.3390/microorganisms9102150. Microorganisms. 2021. PMID: 34683470 Free PMC article.
-
Atmospheric microplastics: exposure, toxicity, and detrimental health effects.RSC Adv. 2023 Mar 8;13(11):7468-7489. doi: 10.1039/d2ra07098g. eCollection 2023 Mar 1. RSC Adv. 2023. PMID: 36908531 Free PMC article. Review.
-
The NagY regulator: A member of the BglG/SacY antiterminator family conserved in Enterococcus faecalis and involved in virulence.Front Microbiol. 2023 Feb 17;13:1070116. doi: 10.3389/fmicb.2022.1070116. eCollection 2022. Front Microbiol. 2023. PMID: 36875533 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources